Tag: rarer

AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer

AstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live 23 months longer than those who received just chemoradiotherapy, according to clinical trial data released Sunday. The finding should help the U.K.-based pharmaceutical company expand the drug’s use in the disease. Researchers in the study, called Adriatic, used Imfinzi […]